AutoICD API

98854-3

Clinical

Urothelial carcinoma probability score based on clinical and lab data

Definition

The likelihood that a patient will have urothelial carcinoma based on lab and clinical data. Urine-derived biomarkers may be used along with additional phenotypic and clinical risk factors to identify patients with hematuria who have a low probability of bladder cancer and may not require a more extensive urological evaluation. To report the algorithm used to determine the urothelial carcinoma probability score, use Risk calculation method used [LOINC: 94561-8].

LOINC 6-Axis Classification

Component

Urothelial carcinoma probability score

Property

Score

Time Aspect

Pt

System

Urine

Scale Type

Qn

Method Type

Based on clinical+lab data

Details

Class

CLIN.RISK

Order/Observation

Both

Short Name

Urothelial Ca prob score clin+lab data

Related Names

Bladder cancerCLIN.RISKfrom clin+lab dataPoint in timeQNTQuanQuantQuantitativeRandomScaleScreUAURUrnUrothelial carcinoma prob score

Frequently Asked Questions

What is LOINC code 98854-3?

LOINC code 98854-3 identifies "Urothelial carcinoma probability score based on clinical and lab data". The likelihood that a patient will have urothelial carcinoma based on lab and clinical data. Urine-derived biomarkers may be used along with additional phenotypic and clinical risk factors to identify patients with hematuria who have a low probability of bladder cancer and may not require a more extensive urological evaluation. To report the algorithm used to determine the urothelial carcinoma probability score, use Risk calculation method used [LOINC: 94561-8].

What does 98854-3 measure?

This code measures Urothelial carcinoma probability score in Urine. It belongs to the CLIN.RISK class in the LOINC classification.

What is LOINC?

LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.